Blood Test Shows Promise for Detecting Cancers Without Approved Screening Tests
A novel blood test can detect cancers that currently have no standard screening procedures, a study suggests.
A novel blood test can detect cancers that currently have no standard screening procedures, a study suggests.
New data highlight the high cost of targeted oral anticancer medicines for patients with Medicare Part D coverage.
Having a high-deductible health plan was associated with a nearly 5-month delay in the diagnosis of metastatic cancer.